FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to imidazole derivatives of general formula 
or its pharmaceutically acceptable salt, wherein R1 means halogen, C1-6-alkyl or C1-6-alkoxy; R2 means C1-6-alkyl; R3 means hydrogen, C1-6-alkyl; Q means -N= or -CH=; R4 represents a group of formula 
or 
, wherein X, Y and Z independently represent -CH= or -N=, and only one of X or Y can be a nitrogen atom; R5 and R6 independently represent a hydrogen atom, C1-6-alkyl, C1-6-hydroxyalkyl, C1-6-alkoxyalkyl, -(CH2)m-(CO)O-C1-6-alkyl, -(CH2)m-S(O)2-C1-6-alkyl, -(CH2)m-C(O)-NR'R" and wherein m=1 and R' and R" independently represent hydrogen or C1-6-alkyl. Also, the invention refers to a therapeutic agent based on the compound of formula (I) and using the compound of formula (I).
EFFECT: there are prepared new imidazole derivatives effective for treating and preventing mGluR5 receptor mediated disorders.
26 cl, 60 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ARYLETHINYL DERIVATIVES | 2011 |
|
RU2573560C2 |
| ETHINYL DERIVATIVES | 2010 |
|
RU2553461C2 |
| PHENYLETHENYL- OR PHENYLETHYNYL-DERIVATIVES AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2001 |
|
RU2284323C9 |
| ETHYNYL DERIVATIVES | 2016 |
|
RU2722014C2 |
| NEW DERIVATIVES OF AMINOPYRIDINE AS ANTAGONISTS mGIuR5 | 2004 |
|
RU2330020C2 |
| HETERO-ARYL SUBSTITUTED DERIVATIVES OF AMIDAZOLE AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2004 |
|
RU2327697C2 |
| TRIAZOLE DERIVATIVES AND APPLICATION THEREOF IN NEUROLOGICAL DISEASES | 2011 |
|
RU2581504C2 |
| IMIDAZOLE III DERIVATIVES | 2004 |
|
RU2360911C2 |
| PYRIDAZINONE-AMIDE DERIVATIVES | 2014 |
|
RU2666899C2 |
| IMIDAZOL DERIVATIVES, METHOD OF THEIR OBTAINING AND THEIR APPLICATION, MEDICATION | 2004 |
|
RU2345074C2 |
